within Pharmacolibrary.Drugs.ATC.D;

model D04AA32
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.72,
    Cl             = 0.00012466666666666667,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0033,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.020833333333333332,
    Tlag           = 900,            
    Vdp             = 0.0024,
    k12             = 1.7,
    k21             = 1.7
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D04AA32</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Diphenhydramine is a first-generation antihistamine, commonly used for the relief of allergic symptoms such as runny nose, sneezing, itching, and urticaria. It is also utilized as a short-term treatment for insomnia, motion sickness, and as an antiemetic. Diphenhydramine is approved and widely used today, though often replaced by newer, non-sedating antihistamines for allergy.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adults, both sexes, after single oral administration.</p><h4>References</h4><ol><li><p>Redmond, JS, et al., &amp; Christensen, JM (2022). Pharmacokinetics of diphenhydramine following single-dose intravenous and oral administration in non-fasted adult horses. <i>Journal of veterinary pharmacology and therapeutics</i> 45(2) 188–195. DOI:<a href=&quot;https://doi.org/10.1111/jvp.13041&quot;>10.1111/jvp.13041</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34921427/&quot;>https://pubmed.ncbi.nlm.nih.gov/34921427</a></p></li><li><p>Ehling, S, et al., &amp; Papich, MG (2019). Diphenhydramine pharmacokinetics after oral and intravenous administration of diphenhydramine and oral administration of dimenhydrinate to healthy dogs, and pharmacodynamic effect on histamine-induced wheal formation: a pilot study. <i>Veterinary dermatology</i> 30(2) 91–e24. DOI:<a href=&quot;https://doi.org/10.1111/vde.12727&quot;>10.1111/vde.12727</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30779257/&quot;>https://pubmed.ncbi.nlm.nih.gov/30779257</a></p></li><li><p>Luna, BG, et al., &amp; Greenblatt, DJ (1989). Doxylamine and diphenhydramine pharmacokinetics in women on low-dose estrogen oral contraceptives. <i>Journal of clinical pharmacology</i> 29(3) 257–260. DOI:<a href=&quot;https://doi.org/10.1002/j.1552-4604.1989.tb03323.x&quot;>10.1002/j.1552-4604.1989.tb03323.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2723113/&quot;>https://pubmed.ncbi.nlm.nih.gov/2723113</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D04AA32;
